Purpose To validate the predictive power for determining breast cancer risk of an automated breast density measurement system with full-fi eld digital mammography (FFDM). Materials and methods Two hundred cancers and 200 controls were imaged with FFDM. Density was measured separately on MLO and CC images using an integral automated volumetric breast density measurement system (Hologic, Quantra). For each cancer, the contralateral mammogram was used. Each cancer was matched to a control case by date of birth, age at examination and laterality of mammogram used for density determination. Breast density (percentage of fi broglandular tissue) was analyzed by Quantra. Data were analyzed by conditional logistic regression to determine the eff ect on breast cancer risk. Results The percentage of breast density ranged from 6% to 63%. Density declined signifi cantly with age (P <0.001). Overall, there was no signifi cant association of density with risk of breast cancer (P = 0.4). There was a suggestive increase in risk with dense volume higher than 35% (OR = 1.80, 95% CI = 0.96 to 3.39, P = 0.07). There was signifi cant heterogeneity by age in the eff ect of density on risk (P = 0.04). In women aged <50, density was signifi cantly associated with increased risk (P = 0.02), with odds ratios of 6.06, 3.98 and 10.59 for density volumes of 15 to 24%, 25 to 34% and ≥35% respectively, relative to those with <15%. In women aged ≥50 years there was no association of density with risk (P = 0.5). Conclusions Quantra automated volumetric breast density measurement is strongly associated with breast cancer risk in women aged under 50, but not in women aged ≥50 years or over.
Introduction NICE guidelines recommend conventional ultrasound (CU) of the axilla as preliminary staging in patients with breast cancer. However, up to one-third of nodes showing normal morphology are metastatic on surgical histology [1] . Ultrasound elastography (UE) uses received radiofrequency data to produce an elastogram depicting tissue stiff ness. UE has been researched in the breast but there are no published data regarding UE of the axilla. Methods Fifty women attending the breast unit as symptomatic GP referrals with breast lesions sonographically suspicious of breast cancer underwent UE of the axilla simultaneously with routine CU examination. Elastograms were visually scored, strain measurements calculated and nodal perimeter and area measurements recorded. UE was compared with CU with histology as the reference standard. Results Twenty-nine nodes were histologically normal, 21 were metastatic. Normal nodes were indistinguishable from surrounding tissue on UE. Using cut-off points for biopsy selected for the study, sensitivity was 90% for UE visual scoring, 100% for strain scoring and 76% for CU. Specifi cities were 86%, 48% and 78% respectively. ROC analysis yielded AUC values of 0.9 for UE visual scoring, 0.86 for strain scoring and 0.82 for CU. There was no signifi cant diff erence between any area and perimeter measurements. Conclusions UE can demonstrate axillary lymph nodes and diff erentiate benign from malignant nodes. UE visual scoring shows greatest promise in improving yield without excessive benign biopsies. Introduction Our screening programme has been fully digital since April 2009 and utilises a combination of computed radiography (CR) (Fuji Profect) and three direct digital mammography (DDM) mammographic systems (Fuji Amulet, GE DS and GE Essential). This study compares the performance of our CR and DDM systems against fi lm screen (FS) mammography in a real-life screening environment. Methods Southern Derbyshire screening episodes between April 2007 and April 2010 were interrogated on NBSS using a Crystal report. Recall and cancer detection rates were collected according to mammography type. Data were analysed for signifi cance using the chi-squared test.
Results A total of 66,989 screening episodes were recorded, 22,039 FS (recall rate 3.23%, cancer detection 8.08/1,000), 30,739 CR (recall rate 2.73%, cancer detection 7.87/1,000) and 14,157 DDM (recall rate 3.87%, cancer detection 9.89/1,000). Recall rates compared with FS were statistically signifi cantly diff erent for CR (P = 0.0007) and DDM (P = 0.0016). Cancer detection rates compared with FS mammography were not signifi cantly diff erent for either CR (P = 0.833) or DDM (P = 0.081), although there was a signifi cant diff erence found between CR and DDM (P = 0.035).
Conclusions DDM in our programme has detected an increased number of cancers but at an increased recall rate. CR has detected a similar number of cancers as FS mammography at a lower recall rate and the study supports the use of CR in our programme. As an interim measure in changing to a fully DDM service it has allowed us to spread costs whilst adopting a single digital workfl ow, which is effi cient and safe for our clients.
Introduction As a part of a retrospective study of computer-aided detection in breast cancer screening, we recorded the percentage of the breast density on a visual analogue scale on 4,866 routine screening mammograms taken in 1996 as part of the North East of Scotland Breast Screening Service. In these women, 284 breast cancers were diagnosed from the time of the original mammograms up until February 2010. Methods The main goal was to evaluate breast density as a breast cancer risk factor by detection mode, histology and time since the original mammogram. The association of density with risk of breast cancer was assessed using logistic regression giving odds ratios per 10% increase in density, and by comparison of continuous mean densities between particular groups of cancers and those who did not develop breast cancer. Results After adjusting for age, breast density was signifi cantly associated with cancer in the fi rst 6 years after the original mammogram (OR per 10% density = 1.08, 95% CI = 1.01 to 1.15, P = 0.03), but not with cancer more than 6 years after the mammogram (OR = 1.01, 95% CI = 0.93 to 1.10, P = 0.8).
There was a statistically signifi cant association between histological type of tumour and breast density (P = 0.02). The mean densities for no cancer, invasive ductal carcinoma, DCIS and invasive lobular carcinoma were 32% (SD 23%), 33% (21%), 35% (26%) and 44% (24%), respectively. The eff ect of density on risk varied signifi cantly by detection mode (P = 0.02), with highest densities being observed in interval cancers arising more than 1 year after the mammogram (55% compared with 32% in those with no cancer).
Conclusions Breast density as measured by visual analogue assessment is strongly associated with late interval cancers and with lobular carcinoma. Its predictive value for risk, however, declines with time since its measurement.
Introduction Flat epithelial atypia (FEA) is seen with increasing frequency following biopsy of calcifi cation detected through screening. FEA is often associated with more signifi cant lesions including atypical ductal hyperplasia and ductal carcinoma in situ (DCIS). It is postulated that FEA may even represent the earliest morphological manifestation of DCIS and a precursor to invasive carcinoma. However, the signifi cance of pure FEA still remains unclear. We aim to review the radiological and pathological features of FEA and evaluate the signifi cance of FEA on needle core biopsy. Methods We performed a retrospective analysis of all needle core biopsies containing FEA in the pathology database from April 2008 to April 2010. For each case the following data were recorded: mammographic features, method of further sampling (mammotome or diagnostic surgical biopsy) and histology from needle core biopsy, mammotome biopsy and surgical biopsy. Results There were 35 needle core biopsies that contained pure FEA, of which 89% (31/35) were associated with mammographic calcifi cation. Following initial core biopsy, 21 patients had further sampling with mammotome biopsy, 13 patients underwent diagnostic surgical biopsy and one patient was not suitable for further intervention. There was an upgrade to DCIS in 18% (6/34) and invasive carcinoma in 3% (1/34).
Conclusions Pure FEA on core biopsy is upgraded to carcinoma in 21% (7/34) of cases on further sampling and it is vital that we do not underestimate the biological signifi cance of FEA. Increasing the awareness of FEA is crucial to ensure consistent and appropriate patient management.
Introduction
In routine breast screening using 2D digital mammography (2DM), mediolateral-oblique (MLO) and craniocaudal (CC) views are performed to maximise cancer detection. Digital breast tomosynthesis (DBT) improves the visibility of lesions by eliminating the problem of superimposition of normal structures, and there is uncertainty regarding the need for two views. The purpose of this study is to compare the accuracy of two-view 2DM with one-view DBT.
Methods Five hundred and one cases were evaluated from the DBT trial dataset of clients recalled for further workup after their initial fi lm-screen mammography. Bilateral two-view 2DM and DBT examination were performed in all study subjects. Mammography scores (1 to 5) based on RCR Breast Group criteria were recorded and an overall score for 2DM was established based on the highest value of MLO and CC scores. Unblinded interpretation of the 2DM followed by MLO-alone DBT was carried out. Statistical analysis was done using the receiver-operative characteristic (ROC). Results There were 111 (22.1%) cancers. The ROC area under the curve (AUC) for two views combined 2DM was 0.915 and for MLO-alone DBT was
Purpose To assess the diagnostic performance of computer-aided detection (CAD) for full-fi eld digital mammography (FFDM) correlated with breast density assessed by an automated breast density measurement system (Hologic, Quantra) in breast cancers and age-matched healthy controls. Materials and methods Two hundred breast cancers imaged with FFDM and 200 age-matched healthy controls were evaluated retrospectively using CAD. A CAD mark was scored true-positive if it correctly indicated a malignant lesion. All other CAD marks were considered false. CAD sensitivity and specifi city were calculated and correlated with mammographic breast density (%).
Results CAD correctly identifi ed 157 of the 200 cancers, a sensitivity of 79%. Sensitivity was suggestively but nonsignifi cantly lower with increased density (P = 0.09). In those cancer cases with density at or below the median of 20%, sensitivity was 82%, compared with 75% in those with density above the median. The presence of one or more false CAD prompts was suggestively but not signifi cantly more likely in controls than cases (87% vs. 80%, P = 0.06). The number of false prompts was signifi cantly higher in controls (average 3.6 vs. 2.6, P <0.001). False prompts were signifi cantly less likely with higher density (P = 0.008). False prompts were present in 86% of cases and controls with density at or below the median, and in 81% of those with density above the median.
Conclusions Increased breast density is signifi cantly associated with higher specifi city of CAD, and there is suggestive evidence that it is also associated with lower sensitivity.
There is debate about the role and optimal organisation of follow-up following treatment for primary breast cancer. We estimated using the best available evidence whether early detection by surveillance of ipsilateral breast tumour recurrence (IBTR) and metachronous contralateral breast cancer (MCBC) was cost-eff ective. Methods An economic model compared alternative surveillance strategies involving mammographic surveillance and/or clinical follow-up performed at diff ering surveillance intervals. The model structure was based upon discussions with the clinical experts involved in the study, a survey of UK breast surgeons and radiologists, and the literature. Data to populate the model came from a series of systematic reviews and an analysis of the West Midlands Cancer Intelligence Unit Breast Cancer Registry. Results of the model were presented as incremental cost per QALYs -a measure of relative effi ciency.
Results
The surveillance strategy most likely to be cost-eff ective was mammographic surveillance alone provided every 12 to 24 months. This result held for women who had previously received either breast-conserving surgery or mastectomy. Results were sensitive to primary tumour characteristics (size, Introduction Women over 70 have poorer breast cancer survival than younger women, and this may be due to late stage at presentation [1] . Promoting early presentation with symptoms in older women attending for their fi nal round of breast screening may reduce stage at diagnosis costeff ectively, and is unlikely to lead to overdiagnosis. We tested the effi cacy of the 10-minute radiographer-delivered Promoting Early Presentation (PEP) Intervention to promote early presentation by increasing breast cancer awareness in the NHS Breast Screening Programme. Methods We randomised 867 women attending their fi nal round of screening to receive the PEP Intervention or usual care, measuring breast cancer awareness at baseline and 1 year. We systematically reviewed the evidence of eff ectiveness of interventions to promote cancer awareness and early presentation.
Results At 1 year, the intervention increased the proportion breast cancer aware compared with usual care (24% vs. 4%; odds ratio = 15.2, 95% CI = 4.8 to 47.8). The systematic review found one randomised trial of a one-to-one intervention that showed a much smaller eff ect on breast cancer awareness.
Conclusions The PEP Intervention is more eff ective than any other intervention to promote breast cancer awareness. It will now be off ered to all women attending for a fi nal mammogram in three NHS breast screening services, to assess costs and feasibility and to measure its eff ect on breast cancer awareness in routine clinical practice. If implemented across the whole Programme, the PEP Intervention has the potential to reduce avoidable deaths from delayed symptomatic presentation in older women. Introduction Velindre Cancer Centre (VCC), Cardiff provides radiotherapy and oncology services to the population of 1.5 million across southeast Wales. Historically at Velindre, breast cancer patients are followed up for at least 10 years, with annual mammography underpinning the service. The optimal length for continued annual surveillance has been debated and reduction to 5 years follow-up suggested. Therefore, a retrospective audit of breast cancers diagnosed on follow-up mammograms was undertaken to support the proposed reduced length of mammographic follow-up. Methods Using the RIS and HIS electronic databases, follow-up mammograms over a 3-year period from 1 June 2006 to 31 May 2009 were collected and their report codes checked. All mammogram reports are coded using the Breast Imaging Reporting and Data System (BI-RADS). All mammograms coded 3 and above were identifi ed. Subsequent radiological and histological reports were reviewed to identify confi rmed malignancies. Results In this 3-year period, there were 6,294 follow-up mammogram examinations at VCC. Ninety-seven reports were coded 3 or above (1.5%). Fifty-six new malignancies were confi rmed. Of these, 44 (79%) occurred more than 5 years from original diagnosis.
Conclusions
The results do not support reducing the length of follow-up to 5 years. Further analysis of original pathology will be undertaken to attempt to risk-stratify patients and thus allow tailored follow-up regimes to be developed.
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An investigation of workstation image manipulation usage when examining FFDM images Y Chen 1 , J James 2 , A Evans 3 , A Turnbull 4 , A Gale 1
Introduction With the introduction of digital breast screening across the UK, screeners need to learn how best to inspect these images. A key advantage over mammographic fi lm is the facility to use workstation image manipulation tools. Methods Forty two-view FFDM screening cases, representing malignant, normal and benign appearances, were examined by 14 radiologists and advanced practitioners from two UK screening centres. For half the cases, the mammography workstation image manipulation tools could be employed; and for the other half these were not used. Participants classifi ed each case and indicated whether an abnormality was present. Throughout the study, the participants visual search behaviour as well as their image manipulations were recorded. Results Whether or not image manipulation tools were used made very little diff erence to overall performance (t test, P >0.05) as confi rmed by JAFROC analysis fi gure-of-merit values of 0.816 and 0.838 (with and without tools, respectively); performance not using tools was better. However, using tools signifi cantly increased inspection time (P <0.5) as well as participants' confi dence. Detailed examination of participants' image inspection behaviour elicited that when imaging tools were used then they spent 17 to 77% of their time manipulating the images; with the less experienced participants spending more time using such tools. Eye movement data demonstrated that when abnormalities were missed then this was typically due to search errors. Conclusions For these cases, whilst using imaging tools was not necessary to identify abnormalities, their use improved confi dence, especially in identifying normal appearances. With experience, less use of such tools was evident. Introduction ShearWave™ elastography (SWE) provides a quantitative measure ment of tissue stiff ness with high spatial resolution and may improve characterization of breast masses. The goal of this study was to evaluate the reproducibility of SWE and the impact of adding SWE features to the BI-RADS classifi cation of breast masses from the fi rst 1,000 cases in a prospective multicenter trial.
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Methods SWE studies were performed on a prototype of the Aixplorer system (Supersonic Imagine, Aix-en-Provence, France). A subset of 192 breast lesions (42.71% malignant) was analyzed. Reproducibility of SWE images and measurements was assessed; logistic regression analysis was performed to predict the pathology fi ndings. SWE features were added to the ultrasound BI-RADS to generate models that were challenged by comparing the areas under the ROC curves (Az), and the sensitivity and specifi city scores.
Results
In the preliminary analysis, intra-operator reproducibility of SWE size (R ≥0.93) and mean elasticity (R = 0.88) measurements were in near-perfect agreement. Using the best three-variable model (BIRADS + elasticity shape + maximum elasticity), the Az increased from 0.77 to 0.93 and specifi city increased from 61.8% to 87.3%, although sensitivity decreased from 92.7% to 87.8%. Adding more variables did not eff ect further improvements.
Conclusions In this ongoing study, SWE provided reproducible information (elasticity values and SWE mapping) that improved the characterization of breast lesions. These features are directly linked to the characteristics of SWE: local quantifi cation and millimeter resolution. Further evaluation of the study is in progress. Conclusions Macrolane™ injection is associated with long-term complications and creates diagnostic challenges on breast imaging that are only beginning to emerge in the breast clinics and that may warrant triple assessment. Introduction Image degradation due to motion artefact in breast MRI represents a diagnostic challenge. Tumours are often detected manually by a radiologist or with computer-aided detection (CAD) systems, which utilise areas of enhancement that meet a predefi ned threshold. The aim of this study was to test a new threshold-independent CAD algorithm and to correlate its fi ndings to the conventional manual analysis.
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Texture analysis applied to full-fi eld digital mammography: ability to discriminate between invasive ductal and invasive lobular breast cancerpreliminary results
Methods CAD was tested on retrospectively acquired MRIs of 14 patients with pathologically proven carcinomas. CAD results were obtained in a fully automated manner and the expert was blinded to the CAD fi ndings. Noise artefacts were eliminated with the patient motion reduction algorithm and suspicious tissues were delineated using a novel all-timepoint-based, threshold-independent parametric map approach. The algorithm evaluates the shape of the curve as a whole and uses the noise integral to the image to discriminate malignant from benign tissues. Results All CAD-identifi ed tumours and generated kinetic curves were comparable with those of the manual analysis. In particular, tumour conspicuity was enhanced in two cases where image degradation by motion artefacts made data interpretation challenging to conventional analysis. See Figure 1 .
Conclusions CAD results were favourably viewed by experts and 100% correlated to conventional manual tumour detection. In particular, CAD appears to increase tumour conspicuity in cases with motion artefacts. Prospective analysis is required to test this model further. Results The mean ADC value of malignant lesions (13) from two small ROIs was 0.954 ± 0.145 mm 2 /second and for benign (2) was 1.69 ± 0.17 mm 2 / second (Figure 1a ). The ADC values for the whole lesion were 1.027 ± 0.23 mm 2 /second and 1.78 ± 0.293 mm 2 /second, respectively (Figure 1b) . Conclusions There is a signifi cant diff erence between ADC values from large and small ROIs (P <0.05), with small ROIs giving greater diff erentiation. DWI is a promising technique to improve specifi city of breast MRI.
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Negative predictive value for atypia and malignancy of 14-gauge core biopsy of breast papillomas GT We identifi ed cases with a 14-gauge core biopsy diagnosis of benign papilloma. Patients with atypia or malignancy on core biopsy were excluded. The imaging features and number of core samples were documented. All patients subsequently underwent lesion excision.
Results Seventy-eight patients had a diagnosis of a benign papilloma on core biopsy. Subsequent excision was with vacuum-assisted biopsy in 48 and surgery in 30. Twenty-eight patients with microcalcifi cation had a stereotactic-guided biopsy. Fifty patients with a mass had ultrasound-guided biopsy. Atypical ductal hyperplasia was found in three out of 28 (11%) who had microcalcifi cation (mean number of 10 cores) and one out of 50 (2%) with a mass (mean number of three cores). Seventy-four (95%) patients had a benign papilloma only.
Conclusions
The NPV for atypia and malignancy of 14-gauge core biopsy of papillomas is 95% in this series. Underestimation of disease is more common in lesions presenting with microcalcifi cation. The current practice of wider sampling of all papillary lesions diagnosed on 14-gauge core biopsy should continue.
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Educational abstract not submitted for online publication. Introduction All breast cancer patients in our centre undergo ipsilateral axillary ultrasound, followed by fi ne needle aspiration (FNA) where appropriate in line with NICE guidelines. We use two needle passes into a suspicious node, without suction. Improved preoperative detection of nodal metastasis allows patients improved triage to appropriate axillary surgery.
We present our analysis of the impact of the second needle in our axillary FNA procedure. Methods All breast cancer patients undergoing axillary FNA from April 2010 to July 2010 were included, where possible. The fi rst FNA was labelled '1' and the second '2' . Individual and overall FNA results were compared with fi nal surgical pathology, where available.
Results
The study included 27 female patients. There was a diff erence in the cytology grading (described LN0 to LN5) allocated between the fi rst and second needle in fi ve cases (19%). The second needle increased sample adequacy on three (11%) occasions. Of the 17 patients that had axillary surgery, three had no lymph node metastases and the preoperative FNA cytology was LN2. There were no false positive cytology results. Preoperative cytology was LN5 overall in 11/14 (79%) patients with nodal metastases, with LN5 obtained only in the second pass in 4/14 (29%) cases (fi rst-pass results: LN2/LN2/LN0/LN0). No complications were reported. Conclusions A second needle pass into suspicious axillary lymph nodes in breast cancer patients has been validated by this study, increasing our preoperative rate of detection of lymph node metastases. Introduction NICE guidelines suggest that patients with lobular breast cancer should be off ered an MRI scan to measure the tumour size and to exclude multifocality and contralateral tumours. The aim of this study was to ascertain the eff ect of this guideline. Methods This guideline was introduced in January 2009. Patients with lobular cancer were selected from before and after this date. Cases were reviewed and compared for type of surgery, positive resection margins and alteration in patient management. The number of additional targeted USS and biopsies was also recorded.
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Fine needle aspiration versus touch imprint cytology in ultrasoundguided core of breast masses
Results Sixty-nine patents were included in the study, of which 22 had preoperative MRI scans. There was no signifi cant diff erence in mastectomy rates (MRI = 45.5% vs. no MRI 57.5%, P = 0.44) and no signifi cant diff erence in positive margins following WLE (MRI 41% vs. no MRI 35%, P = 0.23). Of the 22 MRIs 11 additional fi ndings were reported, six in the contralateral breast, leading to nine targeted USS and eight further core biopsies. Three of these core biopsies confi rmed malignancy. Two MRI scans demonstrated multifocality and one diagnosed contralateral DCIS. Four patients' management was altered due to the MRI result, one of these was due to an increase in size. There was one case of multifocality that was invisible on all imaging.
Conclusions This study has shown that the guideline for preoperative MRI scanning in lobular cancer will alter the surgical management in approximately 20% of patients. An additional 20% of patients will undergo additional imaging and biopsies that do not alter management. 
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Results
The following indications were found -staging scans in patients with locoregional disease: 22%; equivocal radiology: 17%; specifi c concern of recurrent disease: 17%; diagnostic/therapeutic confl ict with second primary: 15%; staging of locally advanced disease: 11%; response to endocrine or chemotherapy: 9%; stability/speed of progression of metastatic disease: 8%. On reviewing clinical records/follow-up, the results of [ 18 F]FDG PET/ CT in many circumstances gave information about metastatic disease in locoregional recurrence, resolved issues surrounding equivocal radiology and ensured that patients with second operable cancers were not subjected to major surgery only to succumb to their breast metastasis.
Conclusions [ 18 F]FDG PET/CT can give valuable information in patients with
breast cancer, particularly in scenarios with equivocal fi ndings on other imaging and regarding disease progression. The technique often contributed to management decisions in complex cases. Results Two hundred and forty cancers were reviewed. In 187 cases (77.9%) the previous round mammograms were normal (group A), in 53 cases (22.1%) an abnormality was detected (group B). Of these, fi ve (9.4%) were classifi ed as normal/benign, 40 (75.5%) were uncertain and eight (15.1%) were suspicious. There was no signifi cant diff erence in the size of the lesions between the two groups; there was, however, a signifi cant increase in size in the lesions in group B on the subsequent mammograms (P <0.0001). Of the lesions in group B, 25 (47%) of the cases had microcalcifi cations only on the previous mammograms; this is higher than previously published data of 27% and 17% [1, 2] with all of these cases being subsequently diagnosed as either DCIS or IDC. Group A had less non-invasive (53, 29%) and grade 3 tumours (26, 20%) compared with group B (non-invasive = 18, 34%; grade 3 = 9, 29%) and more grade 1 tumours (51, 39% vs. 8, 26%) with a similar amount of grade 2 tumours between the groups (41% and 45%).
Conclusions In 22% of incident cancer cases an abnormality is present on the previous screening round mammogram, and the most frequently overlooked lesions are microcalcifi cations.
Introduction There has been increasing interest in the use of vacuumassisted core biopsy (VACB) over the past two decades. There remains some uncertainty about its role in the presence of cytological or architectural atypia on needle core biopsy (NCB). We have recently been off ering VACB for selected B3 cases with atypia. MDT discussion, where technical suitability and potential value of VACB is debated, is used to select appropriate cases. Methods A retrospective case review of all B3 lesions diagnosed at NCB between 1 March 2008 and 1 March 2010. Results A total of 166 B3 lesions were diagnosed: 123 underwent surgical biopsy, of which 30 were malignant (eight invasive, 22 non invasive), 10 had LCIS and 83 were benign. Forty-three B3 lesions underwent VACB: 18/43 lesions had shown atypia at NCB and following VACB, seven were upgraded to DCIS, three were downgraded to B2, six remained as B3 with atypia (5/6 had surgery -three malignant, two benign). VACB failed in two cases. Twenty-fi ve out of 43 cases had shown no atypia at NCB. One out of 25 was upgraded to B4 on VACB, but no malignancy was seen at surgery. Twentyfour out of 25 cases were downgraded to B2. Conclusions Our results show a potential benefi t of this technique in selected cases. We were able to upgrade 39% of B3 lesions with atypia, thereby allowing immediate defi nitive surgery. We were able to avoid surgical excision in 3/18 (17%) of B3 lesions with atypia. Conclusions Based upon questionnaire fi ndings and literature review, guidelines have been now been drawn up in our unit. There is great variation evident in UK gynaecomastia imaging practice. National discussion and agreement on evidence-based guidelines could help rationalize use of precious NHS resources and reduce imaging of this benign condition.
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Introduction Suspicious microcalcifi cation is investigated by vacuumassisted core biopsy. Many patients, in whom malignancy is diagnosed, go on to have breast-conserving surgery where positive resection margins require re-operation. The aim of this study was to determine whether there is an increased risk of positive margins when malignancy is identifi ed in cores without microcalcifi cation. Methods In this institute, core biopsy samples are separated into those containing calcifi cation and those not. Sixty-eight consecutive patients undergoing breast-conserving surgery were selected. From the histology report, the presence of malignancy in each group of cores was recorded. The adequacy of margins following the local excision and the need for reoperation was then analysed.
Results Sixty-eight patients were included in the study. The mean age at diagnosis was 56.7 (range 40 to 77). All 68 patients had malignancy in the cores containing calcifi cation. Twenty-three (34%) patients had malignancy in these cores alone and nine (39%) of these patients required further surgery. Forty-fi ve patients had malignancy in both of the sets of cores, 24 (53%) required further surgery for inadequate margins. Although there is a diff erence between the re-operation rate, this is not statistically signifi cant (P = 0.3124, Fisher's exact test).
Conclusions Malignancy is commonly diagnosed in cores that do not contain microcalcifi cation. Although there appears to be a higher rate of inadequate margins in this group (53% vs. 39%), in this study the diff erence was not statistically signifi cant. Following the fi ndings of this initial study, we are now increasing the sample size of the group. Results Eighty per cent of patients were aged over 50 years (range 50 to 89 years). Nineteen per cent reported a family history. Eighty-nine per cent were grade 3 tumours, 89% were ductal type of which 30% had associated DCIS. The majority were large tumours (78% over 20 mm). Fifty-two per cent were node positive (20% had more than four nodes positive). Thirtynine per cent had associated vascular invasion. Calcifi cation was a dominant mammographic feature (37%), 28% had well-defi ned masses. Conclusions Previous studies have found well-defi ned masses to be a dominant imaging feature but this study has found malignant calcifi cation to be more common. The tumours were mainly large and frequently associated with vascular invasion, possibly contributing to the poor prognosis despite being node negative in nearly one-half of the cases. There appears to be an association with family history and to be common in the over 50s, contrary to current thinking. A national prospectively collected database TNBC could aid understanding of this group. 
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Introduction
All UK screening personnel are invited to take part annually in the PERFORMS self-assessment scheme where they make several judgements about series of challenging recent screening cases. As part of this process they assess the density of each case. Density is a factor known to be associated with a greater risk of developing breast cancer and thus accurate density judgements may well presage the facility to proff er improved follow-up for individual women. The present study examines the degree of variability amongst fi lm reader estimates of breast density on a large number of cases. Methods Data were examined from the most recent 2 years of the PERFORMS scheme where breast density estimates were made for each case examined using a three-point rating scale of fatty, mixed density, and dense. These data comprised information from 444 individuals (mainly consultant radiologists, advanced practitioners and breast physicians) who had all examined the same 240 diffi cult cases.
Results
The inter-rater reliability, corrected for chance agreements, was assessed using kappa. Overall, the degree of agreement across cases on breast density category was signifi cantly greater than no agreement (P <0.0001). However, only a moderate degree of inter-rater reliability was exhibited, κ = 0.470. There were signifi cant diff erences between the levels of agreement amongst the ratings of the radiologists, advanced practitioners and others (all P <0.05).
Conclusions The low agreement rates between participants for density ratings were surprising. That there were diff erences between the occupational groupings may refl ect breast screening experience.
Introduction
The prevalent round recall rate is higher than the incident recall rate. Implementation of age extension will lead to two prevalent rounds and with this increased clinical and fi nancial pressure on screening units. Any processes that help reduce the recall rate will be of benefi t to screening units. Methods Retrospective data were collected from April 2008 to March 2009 of prevalent round ladies recalled to assessment clinics. The data recorded included reason for recall, imaging fi ndings and needle test results. Results A total of 7,627 women were invited for screening in April 2008 to March 2009, of which 5,341 attended. Four hundred and eighty-one ladies were recalled to assessment; 451/481 of the packets available were reviewed. Forty cancers were identifi ed in 39 patients. All cases of malignancy were coded as RU, RS or RM at the time of fi lm reading. Thirty-two patients were recalled for both sides, four patients recalled for two lesions within the same breast. Nineteen patients were clinical recalls (BA). All solitary RB masses thought to be benign at the time of fi lm reading proved to be benign (91/215 masses). Ten cases recalled for bilateral RB masses were benign. Thirty-six out of 140 asymmetries thought to be benign at the time of fi lm reading were benign.
Conclusions The recall rate may be reduced in the prevalent round by not recalling solitary RB masses, bilateral RB masses, and asymmetry that appears physiological/benign on two views. In this unit this would have reduced the recall rate without adversely aff ecting the cancer detection rate.
The aim of breast reconstruction in the postmastectomy cancer patient is to restore breast contour and dimensions whilst minimising the cosmetic impact. The deep inferior epigastric perforator (DIEP)-fl ap is a complex but state-of-the-art procedure that provides a durable and natural result. It is rapidly becoming the preferred choice at many institutions, including our regional plastic surgery unit. In achieving superior cosmesis without sacrifi cing abdominal wall musculature, a successful DIEP-fl ap requires painstaking and time-consuming microdissection of the inferior epigastric artery perforators. This relies on a high level of surgical expertise and results in prolonged anaesthetic times. As greater volumes of breast reconstructive surgery are performed, there will be increasing requirements for such preoperative imaging. We describe the required optimisation of CTA protocols to obtain the pertinent information and demonstrate how best to convey this complex information to our surgical colleagues.
Methods Since 2009 we have provided CT-angiography in the preoperative planning for DIEP-fl ap breast reconstruction. We explored the implications of CT-angiography to optimise localisation of arterial perforators and identifi ed the benefi ts of this imaging-guided approach.
Results A total of 60 female patients have benefi tted from CTA-guided perforator localisation, providing valuable procedural-planning information to our surgical colleagues. We have shown benefi ts in terms of markedly shorter operative duration with consequently reduced hospital stays and morbidity. Two patients had unsuspected metastatic disease identifi ed, precluding reconstructive surgery.
Conclusions An imaging-guided approach optimises preoperative planning. Accurate identifi cation of arterial perforators enables targeted intraoperative localisation. This results in decreased operative time and patient morbidity, providing benefi ts for the cost of healthcare provision. Introduction Studies estimate that 10 to 32% of breast cancers are overlooked in mammograms. One of the important causes of interval breast cancer is fatigue and loss of concentration. The likelihood of fatigue increases with the duration of a reporting session and errors are more likely to occur towards the end of the session. The purpose of this talk is to address the lack of awareness of the issues that drive reporting performance. Methods A retrospective study was carried out on interval breast cancers from a 2-year period. This identifi ed 90 histopathologically proven interval breast cancers. Each interval cancer mammogram was reviewed by two blinded consultant radiologists and placed into one of three categories on retrospective radiological review: Category 1: normal; Category 2: uncertain; Category 3: suspicious. Each case was then analysed further to correlate the interval categories with their position on the mammography roller viewer. Results Of the 90 interval breast cancers, 59 (66%) were Category 1, 14 (16%) were Category 2 and 17 (18%) were Category 3. Statistical analyses with one-way ANOVA test revealed the presence of clinical signifi cance between Category 3 cases and their position in the roller viewer (P <0.021).
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Conclusions Fatigue is identifi ed as an important factor responsible for missing breast cancer. Aside from making changes in double-reporting techniques, human performance factors such as nutrition, rest, behaviour prior to reporting and environment have to be considered. A national programme has to be implemented to facilitate a plan to raise awareness of these factors in the NHS culture. This study was based on the hypothesis that recall of benign solitary masses might be a major contributor to this as no prior imaging is available. Methods Prospectively collected data from Breast Test Wales (South East Wales) identifi ed all prevalent screens in a 3-year cycle recalled for a benign mass lesion confi rmed by core biopsy. All women attended a subsequent screen and remained free of cancer. Mammograms were retrospectively reviewed and the lesions were re-evaluated by applying criteria typical of a benign mass. Results A total of 2,322 women following a prevalent screen were recalled; 2,069 were returned to routine recall without biopsy (cysts are included in this group), 186 were diagnosed with cancer and 105 had a benign biopsy where mammography had been considered benign or probably benign. The benign to malignant biopsy ratio was 1:1.8. A total 46.6% (n = 49) lesions on retrospective review of mammography showed typical benign characteristics. Dense breast composition and overlying glandular tissue were noted to correlate with higher rates of retrospectively indicated recall.
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Conclusions Stricter adherence to applying classifi cation of benign solitary lesions could reduce the recall rate and decrease the psychological distress for these women without adversely compromising the cancer detection rate. The impact on the overall recall rate would be small but would signifi cantly improve the benign to malignant biopsy ratio. The issue of breast density and overlying tissue may be resolved with the advent of digital applications such as tomosynthesis.
Introduction Around 5% of breast cancers can be attributed to gene mutations. NICE guidelines have recently advocated the use of MRI screening in high-risk young women. We have retrospectively audited our unit's experience in this fi eld. Methods All eligible women were identifi ed from the family history database. Notes, imaging and pathology were reviewed. Results One hundred and thirty-three breast MRI scans were performed on 91 women with a high-risk family history between 2007 and 2010. Sixteen women were recalled for assessment (one woman was recalled twice). The total recall rate was 12.7%. Of the recalled patients, four had normal ultrasound (US) and follow-up imaging has remained unchanged. Thirteen patients had corresponding US-detected abnormalities. Twelve were biopsied, the other was a normal intramammary lymph node. Eight of the biopsies were benign (benign core biopsy rate 6%). Four biopsies were malignant (age range of women 35 to 45), giving a cancer detection rate of 3%. Three of these were solitary lesions (8 mm, 11 mm and 16 mm). One patient had multifocal malignancy, the largest single lesion being 16 mm. All were node-negative ductal carcinoma. Two patients were oestrogen receptor-positive, all were herceptin receptor-negative. Only the extensive malignant change could be seen on conventional mammography. Conclusions We suggest that MRI screening is benefi cial in these patients, and although our recall rate lies a little above what is to be recommended by the NHSBSP (7 to 10%) we feel this can be attributed to the steep learning curve that introducing a new screening technique to a service invariably brings.
